Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Qing Xu"'
Autor:
Li Feng, Jiao Zhu, Xiujing He, Yunfan Yin, Ming Zhang, Ming-Qing Xu, Xiaobo Zheng, Jing Yu, Chune Yu
Publikováno v:
Aging (Albany NY)
As a key mechanism, alternative splicing (AS) plays a role in the cancer initiation and development. However, in papillary thyroid cancer (PTC), data for the comprehensive AS event profile and its clinical implications are lacking. Herein, a genome-w
Autor:
Ming-Qing Xu, Yitao Hu, Liangliang Xu, Xiangyong Hao, Ming Zhang, Tian Lan, Kefei Yuan, Xiaobo Zheng, Jianwei Tang, Xinfu Feng, Lian Li, Yanfang Zhang, Shengsheng Ren, Peng Wang, Jinfu Zhang
Publikováno v:
Clinical Science. 133:2085-2105
A previous study reported that histone methyltransferase SETD3 is up-regulated in tumor tissues of hepatocellular carcinoma (HCC) and is associated with the growth of HCC. However, the clinical significance and the effect of SETD3 on HCC metastasis r
Prognostic Value of an Immunohistochemical Signature in Patients With Head and Neck Mucosal Melanoma
Autor:
Shao-Han Yin, Qing-Qing Xu, Cheng-Long Huang, Mu-Yan Cai, Qing-Jie Li, Li-Xia Lu, Mei-Fang Zhang, Lei Chen
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
PurposeWe aimed to develop a prognostic immunohistochemistry (IHC) signature for patients with head and neck mucosal melanoma (MMHN).MethodsIn total, 190 patients with nonmetastatic MMHN with complete clinical and pathological data before treatment w
Autor:
Lian Li, Shengsheng Ren, Yanfang Zhang, Xinfu Feng, Peng Wang, Xiaobo Zheng, Liangliang Xu, Ming-Qing Xu, Xiangyong Hao, Ming Zhang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-15 (2019)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
Background Circular RNAs (circRNAs) play important roles in tumourigenesis and tumour progression. However, the expression profiles and functions of circRNAs in hepatocellular carcinoma (HCC) are largely unclear. Methods The expression profiles of ci
Publikováno v:
Journal of Immunology Research
Journal of Immunology Research, Vol 2021 (2021)
Journal of Immunology Research, Vol 2021 (2021)
Mitochondrial Pyruvate Carrier 1 (MPC1), one of the rate-limiting proteins involved in glycolysis metabolism, has been demonstrated as a tumor inhibitor in several cancers. This study was conducted with the aim of exploring the role and underlying me
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Background Programmed cell death-1 (PD-1) blockade immunotherapies have demonstrated excellent clinical benefits in multiple cancers, but < 20% of melanoma patients respond to these treatments. Thus, it is crucial to understand for getting awareness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b03f478219eea93600b4b9fd65ecf15
https://doi.org/10.21203/rs.3.rs-83300/v1
https://doi.org/10.21203/rs.3.rs-83300/v1
Publikováno v:
IUBMB lifeReference. 72(8)
microRNA-3607 (miR-3607) has been identified as an important biomarker, and its aberrant expression exerts a significant role in tumorigenesis. However, the biological function of miR-3607 in hepatocellular carcinoma (HCC) needs to be deciphered comp
Publikováno v:
Pathology - Research and Practice. 213:1563-1567
Caprin-1 has been found to promotes osteosarcoma tumor growth, lung metastasis in mice, regulating the proliferation and invasion of human breast cancer cells and up-regulated in proton beam irradiated human melanoma cells. However, its clinical role
Publikováno v:
Oncotarget
// Longci Sun 1 , Chunhui Jiang 1 , Chunjie Xu 1 , Hanbing Xue 2 , Hong Zhou 1 , Lei Gu 1 , Ye Liu 1 , Qing Xu 1 1 Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China 2 Div
Autor:
Gang Chen, Wen-Qing Xu, Yu-Ji Chen, Hui-Mei Huang, Yi-Nan Guo, Ke Shi, Zuyun Li, Shu-Ping Huang, Ting-Qing Gan, Kang-Lai Wei
Publikováno v:
Respiratory Research
Respiratory Research, Vol 20, Iss 1, Pp 1-18 (2019)
Respiratory Research, Vol 20, Iss 1, Pp 1-18 (2019)
Background Previous studies have shown that miR-144-3p might be a potential biomarker in non-small cell lung cancer (NSCLC). Nevertheless, the comprehensive mechanism behind the effects of miR-144-3p on the origin, differentiation, and apoptosis of N